doi: 10.3389/fimmu.2024.1476859 Received 06 August 2024 Accepted 03 December 2024 Published 19 December 2024 Volume 15 - 2024 Edited by Carmelo Carmona-Rivera, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH), United States Reviewed by Jos Jiram Torres-Ruiz, National Institute of Medical Sciences and Nutrition Salvador Zubirn, Mexico Matteo Doglio, San Raffaele Hospital (IRCCS), Italy Lauren Robinson, Hospital for Special Surgery, United States Updates Copyright 2024 Zhou, Lei, Shi, Luo, Wu, Xu, Zhang, Liu, Wang, Zhou and He
NAD+ Discover the rejuvenating power of NAD+ to support cellular health and energy
Liu, S., Neidhardt, E
The primary antibodies that were used were as follows: antibodies against cardiac troponin T (#ab209813, 1: 3000 for cardiomyocytes), antibodies against Col11 (#ab270993, 1:2000), antibodies against Vimentin (#ab24525, 1:300) and cardiac troponin T (#ab8295, 1: 2000 for myocardial tissue) were obtained from Abcam (Cambridge, UK)
In human studies, increased physical activity has been associated with a reduced prevalence of hepatic steatosis, and a recent randomized control trial has shown that 12 months of moderate-intensity exercise in patients with T2DM resulted in reduced hepatic triglyceride content (286289)
